Skip to main content
Premium Trial:

Request an Annual Quote

Proteros Inks Deal to Provide Access to UC DCC's Screening Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein structure analysis firm Proteros today announced a deal with the University of Cincinnati, Drug Discovery Center to provide biotechnology and drug firms access to UC DDC's ultra-high throughput and high-content screening platform along with a library of more than 340,000 drug-like compounds.

Proteros, based in Martinsried, Germany, will serve as a single point of contact and be responsible for all client interactions and project management.

Financial and other terms of the deal were not disclosed.

"This powerful academic-industry collaboration in translational research combines leading capabilities at the UC DDC with Proteros' proven technical and commercial expertise in providing discovery services and will continue to expand our base of pharmaceutical and biotechnology clients," Ruben Papoian, director of UC DDC, said in a statement.